In older clients, this is crucial to know as polypharmacy is popular and might potentiate the risk of DDIs and ADRs. Consequently, concurrent consumption of CYP2D6 inhibitors or inducers could potentiate or block tramadol conversion into ODT and this could boost or reduce efficacy/ADRs with the prescribed tramadol. Literature describing the nominal